Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM) (SETAM)
Investigation on Early Detection and Active Management of Supra-ventricular Arrhythmia With Telecardiology
Sponsor: Biotronik France
This NA trial investigates Atrial Fibrillation and Atrial Flutter and is currently completed. Biotronik France leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biotronik France
- Biotronik SE & Co. KG
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Abbeville, France , Aix-en-Provence, France , Annecy, France , Argenteuil, France , Arras, France , Aurillac, France , Auxerre, France , Avignon, France , Blois, France , Bourges, France and 46 more locations